天美传媒

Abstract

Metabolomics, the comprehensive study of metabolites within biological systems, has emerged as a critical field in oncology, offering new insights into cancer biology and paving the way for the development of targeted cancer therapies. By profiling the unique metabolic signatures of cancer cells, researchers can identify specific metabolic pathways that are altered in different types of cancer. This approach facilitates the discovery of novel biomarkers for early diagnosis, prognosis, and therapeutic targets. Targeted therapies developed through metabolomics can inhibit cancer-specific metabolic pathways, leading to more effective treatments with fewer side effects compared to conventional therapies. Additionally, metabolomics provides a deeper understanding of tumor heterogeneity and drug resistance mechanisms, allowing for the design of personalized treatment strategies. As technology advances, integrating metabolomics with other omics disciplines and clinical data holds great promise for revolutionizing cancer therapy, offering hope for more precise, individualized, and effective treatments for cancer patients.